NCT06638931 2026-04-15ANTARESInstituto do Cancer do Estado de São PauloPhase 2 Recruiting28 enrolled
NCT06521567 2025-11-12A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerGlaxoSmithKlinePhase 1/2 Active not recruiting83 enrolled